ASSEMBLY BIOSCIENCES, INC. (ASMB)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $674
- Jun 17 · No plan
- Form 4 sales
- 70
- On record
- Form 144 notices
- 8
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planNov 18 2024
Sold 40 shares at $16.29 ($652)
White Nicole S, Chief Manufacturing Officer
No 10b5-1 planSold 0.3% of holdings ($194k position)11,871 shares left0.1x usual sizeFiling
- 2 Form 4 saleNo planMar 31 +133 days
Sold 197 shares at $9.85 ($2k)
White Nicole S, Chief Manufacturing Officer
No 10b5-1 planSold 1.7% of holdings ($117k position)11,674 shares left0.6x usual sizeFiling
- 3 Form 4 saleNo planMar 31 same day
Sold 355 shares at $9.85 ($3k)
Okazaki Jason A, CEO and President
No 10b5-1 planSold 2.3% of holdings ($149k position)14,757 shares left0.4x usual sizeFiling
- 4 Form 4 saleNo planMar 31 same day
Sold 180 shares at $9.85 ($2k)
Bjorkquist Jeanette M, Principal Accounting Officer
No 10b5-1 planSold 3.8% of holdings ($47k position)4,617 shares left0.9x usual sizeFiling
- 5 Form 4 saleNo planMar 31 same day
Sold 757 shares at $9.85 ($7k)
McHutchison John G, Director
No 10b5-1 planSold 4% of holdings ($188k position)18,347 shares left0.4x usual sizeFiling
- 6 Form 4 saleNo planMar 30 +364 days
Sold 197 shares at $26.69 ($5k)
White Nicole S, Chief Manufacturing Officer
No 10b5-1 planSold 0.5% of holdings ($1M position)37,477 shares left1x usual sizeFiling
- 7 Form 4 saleNo planMar 30 same day
Sold 328 shares at $26.69 ($9k)
Bjorkquist Jeanette M, PFO and PAO
No 10b5-1 planSold 2.9% of holdings ($305k position)11,089 shares left2.9x usual sizeFiling
- 8 Form 4 saleNo planJun 17 +79 days
Sold 29 shares at $23.25 ($674)
Bjorkquist Jeanette M, PFO and PAO
No 10b5-1 planSold 0.2% of holdings ($339k position)14,560 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (78)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Bjorkquist Jeanette M | PFO and PAO | Form 4 sale | 29 | $674 | 0.2% | No plan | SEC |
| Mar 30, 2026 | Bjorkquist Jeanette M | PFO and PAO | Form 4 sale | 328 | $9k | 2.9% | No plan | SEC |
| Mar 30, 2026 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 197 | $5k | 0.5% | No plan | SEC |
| Mar 31, 2025 | McHutchison John G | Director | Form 4 sale | 757 | $7k | 4.0% | No plan | SEC |
| Mar 31, 2025 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 180 | $2k | 3.8% | No plan | SEC |
| Mar 31, 2025 | Okazaki Jason A | CEO and President | Form 4 sale | 355 | $3k | 2.3% | No plan | SEC |
| Mar 31, 2025 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 197 | $2k | 1.7% | No plan | SEC |
| Nov 18, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 40 | $652 | 0.3% | No plan | SEC |
| Oct 3, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 157 | $2k | 1.3% | No plan | SEC |
| Oct 3, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 197 | $3k | 1.3% | No plan | SEC |
| Aug 2, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 785 | $11k | 6.1% | No plan | SEC |
| Aug 2, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 981 | $14k | 6.1% | No plan | SEC |
| May 23, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 24 | $358 | 0.8% | No plan | SEC |
| May 23, 2024 | McHutchison John G | Director | Form 4 sale | 2,117 | $32k | 10.0% | No plan | SEC |
| May 23, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 549 | $8k | 3.3% | No plan | SEC |
| May 23, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 172 | $3k | 1.3% | No plan | SEC |
| Apr 30, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 1,255 | $16k | 8.8% | No plan | SEC |
| Apr 30, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 1,569 | $20k | 8.7% | No plan | SEC |
| Apr 1, 2024 | McHutchison John G | Director | Form 4 sale | 1,206 | $16k | 5.4% | No plan | SEC |
| Apr 1, 2024 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 114 | $1k | 3.5% | No plan | SEC |
| Apr 1, 2024 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 197 | $3k | 1.8% | No plan | SEC |
| Apr 1, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 354 | $5k | 2.5% | No plan | SEC |
| Mar 27, 2024 | Okazaki Jason A | CEO and President | Form 4 sale | 392 | $5k | 2.7% | No plan | SEC |
| Nov 17, 2023 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 477 | $329 | 0.5% | No plan | SEC |
| Oct 3, 2023 | White Nicole S | Chief Manufacturing Officer | Form 4 sale | 1,891 | $2k | 2.0% | No plan | SEC |
| Oct 3, 2023 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 1,891 | $2k | 1.2% | No plan | SEC |
| Oct 3, 2023 | Okazaki Jason A | CEO and President | Form 4 sale | 2,363 | $2k | 1.3% | No plan | SEC |
| Oct 3, 2023 | Delaney William E IV | Officer | Form 144 notice | 1,891 | $2k | Notice | SEC | |
| Oct 3, 2023 | Okazaki Jason A | Officer, Director | Form 144 notice | 2,363 | $2k | Notice | SEC | |
| Aug 2, 2023 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 9,461 | $10k | 6.2% | No plan | SEC |
| Aug 2, 2023 | Okazaki Jason A | CEO and President | Form 4 sale | 11,827 | $13k | 6.7% | No plan | SEC |
| Aug 2, 2023 | Okazaki Jason A | Officer, Director | Form 144 notice | 11,827 | $13k | Notice | SEC | |
| Aug 2, 2023 | Delaney William E IV | Officer | Form 144 notice | 9,461 | $10k | Notice | SEC | |
| Jul 24, 2023 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 844 | $903 | 3.1% | No plan | SEC |
| May 30, 2023 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 4,232 | $4k | 3.6% | No plan | SEC |
| May 30, 2023 | Delaney William E IV | Officer | Form 144 notice | 4,232 | $4k | Notice | SEC | |
| May 23, 2023 | McHutchison John G | Director | Form 4 sale | 25,972 | $27k | 13.3% | No plan | SEC |
| May 23, 2023 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 274 | $285 | 1.0% | No plan | SEC |
| May 23, 2023 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 6,561 | $7k | 5.3% | No plan | SEC |
| May 23, 2023 | Okazaki Jason A | CEO and President | Form 4 sale | 6,561 | $7k | 4.9% | No plan | SEC |
| May 23, 2023 | Delaney William E IV | Officer | Form 144 notice | 6,561 | $7k | Notice | SEC | |
| May 23, 2023 | Okazaki Jason A | Officer, Director | Form 144 notice | 6,561 | $7k | Notice | SEC | |
| May 23, 2023 | McHutchison John G | Director | Form 144 notice | 25,972 | $27k | Notice | SEC | |
| Mar 30, 2023 | McHutchison John G | Director | Form 4 sale | 14,883 | $12k | 7.7% | No plan | SEC |
| Mar 30, 2023 | Bjorkquist Jeanette M | Principal Accounting Officer | Form 4 sale | 774 | $635 | 3.1% | No plan | SEC |
| Mar 30, 2023 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 3,421 | $3k | 3.8% | No plan | SEC |
| Mar 30, 2023 | Okazaki Jason A | CEO and President | Form 4 sale | 4,247 | $3k | 4.1% | No plan | SEC |
| Mar 27, 2023 | Okazaki Jason A | CEO and President | Form 4 sale | 4,693 | $5k | 4.4% | No plan | SEC |
| Aug 8, 2022 | McHutchison John G | Chief Executive Officer | Form 4 sale | 12,314 | $26k | 6.0% | Plan not stated | SEC |
| Jul 25, 2022 | Samar Michael P. | Chief Financial Officer | Form 4 sale | 2,020 | $4k | 2.5% | Plan not stated | SEC |
| May 31, 2022 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 4,164 | $8k | 5.2% | Plan not stated | SEC |
| Mar 30, 2022 | Samar Michael P. | Chief Financial Officer | Form 4 sale | 2,285 | $5k | 2.9% | Plan not stated | SEC |
| Mar 30, 2022 | Stamm Luisa M | Chief Medical Officer | Form 4 sale | 1,038 | $2k | 2.5% | Plan not stated | SEC |
| Mar 30, 2022 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 1,038 | $2k | 1.3% | Plan not stated | SEC |
| Mar 30, 2022 | Okazaki Jason A | Chief Operating Officer | Form 4 sale | 1,269 | $3k | 1.3% | Plan not stated | SEC |
| Mar 30, 2022 | McHutchison John G | CEO and President | Form 4 sale | 4,614 | $10k | 2.2% | Plan not stated | SEC |
| Mar 28, 2022 | Okazaki Jason A | Chief Operating Officer | Form 4 sale | 4,617 | $10k | 6.7% | Plan not stated | SEC |
| Aug 9, 2021 | McHutchison John G | CEO and President | Form 4 sale | 12,156 | $44k | 8.8% | Plan not stated | SEC |
| May 27, 2021 | Delaney William E IV | Chief Scientific Officer | Form 4 sale | 4,129 | $17k | 7.2% | Plan not stated | SEC |
| Dec 14, 2020 | Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Form 4 sale | 1,297 | $8k | 3.4% | Plan not stated | SEC |
| Nov 9, 2020 | Stamm Luisa M | Chief Medical Officer | Form 4 sale | 4,397 | $22k | 36.6% | Unusual | SEC |
| Aug 7, 2020 | McHutchison John G | CEO and President | Form 4 sale | 12,151 | $265k | 8.1% | Plan not stated | SEC |
| Mar 31, 2020 | Colonno Richard James | EVP & CSO, Virology Ops | Form 4 sale | 7,812 | $117k | 5.4% | Plan not stated | SEC |
| Mar 30, 2020 | Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Form 4 sale | 1,254 | $18k | 3.1% | Plan not stated | SEC |
| Dec 13, 2019 | Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Form 4 sale | 1,460 | $31k | 6.0% | Plan not stated | SEC |
| Dec 12, 2019 | Colonno Richard James | EVP & CSO, Virology Ops | Form 4 sale | 33,061 | $827k | 20.5% | Plan not stated | SEC |
| Sep 6, 2018 | Lopatin Uri A | Chief Med. Off., VP Res. Dev. | Form 4 sale | 15,540 | $623k | 2.5% | Plan not stated | SEC |
| Jul 2, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $39k | 4.9% | Plan not stated | SEC |
| Jun 1, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $42k | 4.9% | Plan not stated | SEC |
| May 1, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $43k | 4.9% | Plan not stated | SEC |
| Apr 2, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $49k | 4.9% | Plan not stated | SEC |
| Mar 1, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $56k | 4.9% | Plan not stated | SEC |
| Feb 1, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $47k | 4.9% | Plan not stated | SEC |
| Jan 2, 2018 | Ringo William R | Director | Form 4 sale | 1,000 | $45k | 4.9% | Plan not stated | SEC |
| Dec 1, 2017 | Ringo William R | Director | Form 4 sale | 1,000 | $49k | 4.9% | Plan not stated | SEC |
| Nov 1, 2017 | Ringo William R | Director | Form 4 sale | 1,000 | $30k | 4.9% | Plan not stated | SEC |
| Oct 16, 2017 | Ringo William R | Director | Form 4 sale | 1,000 | $34k | 4.9% | Plan not stated | SEC |
| May 12, 2017 | Ringo William R | Director | Form 4 sale | 3,461 | $76k | 100.0% | Unusual | SEC |